The FDA is about to make weight-loss drugs a lot harder to get
Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
Le Lézard7d
FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease
Omvoh is the first biologic treatment in more than 15 years to have disclosed two-year Phase 3 efficacy data in Crohn's disease at the time of approval. 2 "The burden of Crohn's disease on patients' ...
Osteoporosis screening guidelines updated: Do you need a bone scan?
“The term osteoporosis screening refers to use of bone density, x-ray studies or other tools to identify persons at an increased risk of fractures or bone breaks,” Dr. Thomas Weber, an endocrinologist ...
Chronic Pain Is a Hidden Epidemic. It’s Time for a Revolution.
I would have been bored, except the pain was so tiring that I could barely function. I spent the days shuffling around the ...
How food brands and drugmakers are responding to FDA’s ban of food dye Red 3
Companies say they are working to update their products to comply with the Food and Drug Administration's decision ...
NJBIZ16d
GLP-1 users spend less at the supermarket, Cornell study finds
As the weight-loss drugs become more popular, consumer habits are starting to reflect changing consumption behavior, including decreasing sales for certain kinds of foods.
Medscape4d
Rivaroxaban for Stroke Prevention in Atrial Fibrillation
Eli-Lilly, GlaxoSmithKline, Johnson & Johnson, Pfizer and Sanofi. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest ...
pharmaphorum7d
Eisai debuts biliary tract cancer drug in Japan
Meanwhile, the company also launched its Rozebalamin (ultra-high-dose mecobalamin) vitamin B12 product for ... prescribed off-label for the disease. Eli Lilly picks up a second FDA approval ...